BNP Guided Care in Addition to Multidisciplinary Care
NT-BNP Guided Care in Addition to Multidisciplinary Care in Patients With Chronic Heart Failure A Three-Arm, Prospective, Randomised Study
1 other identifier
interventional
N/A
0 countries
N/A
Brief Summary
HF is associated with repeated hospitalisations and poor prognosis.The aim of this study is to investigate whether BNP-guided care (BGC) in addition to multidisciplinary management(MM) improves outcome compared to HNC alone or usual care (UC) for decompensated HF patients after discharge. Patients hospitalised with cardiac decompensation in 9 Viennese hospitals are randomised to BGC, MM alone, or UC. MM includes 2 consultations of a heart failure (HF) specialist 10 days and 2 months after discharge for recommending medical optimisation and care by a specialised HF nurse including 4 home visits and telephone contact. In addition, BGC includes intensified increase of medical treatment during repeated follow-up visits in a HF clinic in patients with an Nt-BNP level above 2200pg/ml at discharge.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Sep 2003
Typical duration for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2003
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2005
CompletedFirst Submitted
Initial submission to the registry
July 19, 2006
CompletedFirst Posted
Study publicly available on registry
July 20, 2006
CompletedOctober 18, 2006
July 1, 2006
July 19, 2006
October 17, 2006
Conditions
Outcome Measures
Primary Outcomes (2)
Heart failure rehospitalisation rate;
combined endpoint death or heart failure rehospitalisation;
Interventions
Eligibility Criteria
You may qualify if:
- Clinical signs and symptoms of cardiac decompensation during the present hospitalisation
- NYHA class III or IV at time of admission
- Cardiothoracic ratio \> 0.5, and/or left ventricular ejection fraction \<40% documented by echocardiography
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (1)
Berger R, Moertl D, Peter S, Ahmadi R, Huelsmann M, Yamuti S, Wagner B, Pacher R. N-terminal pro-B-type natriuretic peptide-guided, intensive patient management in addition to multidisciplinary care in chronic heart failure a 3-arm, prospective, randomized pilot study. J Am Coll Cardiol. 2010 Feb 16;55(7):645-53. doi: 10.1016/j.jacc.2009.08.078.
PMID: 20170790DERIVED
Study Officials
- PRINCIPAL INVESTIGATOR
Richard Pacher, MD
Medical University of Vienna
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
July 19, 2006
First Posted
July 20, 2006
Study Start
September 1, 2003
Study Completion
September 1, 2005
Last Updated
October 18, 2006
Record last verified: 2006-07